Home | Welcome to Contract Pharma   
Last Updated Tuesday, May 21 2013
Print RSS Feed

Breaking News

Related Searches: Collaborations & Alliances •
Evotec, Merck KGaA Enter CNS Development Pact

November 23, 2010
Evotec AG, through the NEU(2) consortium, has signed an agreement with Merck KGaA to develop pre-clinical candidates for an undisclosed neurological disease.   Read More »
Bayer, Regeneron Wet AMD Drug Shows Promise

November 22, 2010
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare achieved positive results from two parallel Phase III studies in patients with the neovascular form of age-related macular degeneration (wet AMD), with all regimens of VEGF Trap-Eye (aflibercept ophthal  Read More »
Penn Pharma

November 22, 2010
Edward Rowland has been appointed head of operational analytical services for Penn Pharma.   Read More »
Lancaster Labs Launches New Mycoplasma Assay

November 22, 2010
Lancaster Laboratories has introduced a new cGMP compliant mycoplasma assay, harmonizing both United States Pharmacopeia (USP) Chapter <63> monograph and European Pharmacopoeia Chapter 2.6.7 guidelines.  Read More »
Boehringer, F-star Enter Antibody Pact

November 22, 2010
Boehringer Ingelheim and F-star, an antibody engineering company based in Vienna, Austria, have entered a collaboration and license agreement for the discovery of new antibody-derived therapeutic products using F-star’s Modular Antibody Technology.  Read More »
Bayer Cuts Jobs in Restructuring Effort

November 19, 2010
Bayer plans to restructure in order invest its resources in growing the company and enhancing its capabilities.   Read More »
Baxter Acquires Hemophilia Assets from Archemix

November 19, 2010
Baxter has entered into a definitive agreement to acquire all of the hemophilia-related assets of Archemix, a privately-held biopharmaceutical company.  Read More »
Amgen's Deonsumab Approved for Bone Metastases

November 19, 2010
Amgen received approval from the FDA for XGEVA (denosumab), the first RANK Ligand inhibitor for the prevention of skeletal-related events (SREs) in patients with bone metastases from solid tumors.  Read More »
Pfizer’s Phase III Cancer Trial Meets Endpoint

November 19, 2010
Pfizer’s Phase III trial studying the investigational compound axitinib in previously treated patients with metastatic renal cell carcinoma (mRCC) met its primary endpoint, demonstrating significantly extended progression-free survival (PFS) when co  Read More »
Roche To Restructure, Lay off 4,800

November 17, 2010
Setbacks after Genentech acquisition lead to $2.4 billion cost-cutting  Read More »
Quintiles, Kadrige in Commercialization Pact

November 17, 2010
U.S., EU deal to speed hybrid detailing model  Read More »
Eisai, FORMA in Discovery Pact

November 17, 2010
DOS platforms to support Eisai portfolio  Read More »
FDA Approves Eisai Breast Cancer Treatment

November 16, 2010
Halaven injection adds new option in metastatic breast cancer  Read More »
Avecia Brings in BioTechLogic for QMS Assist

November 16, 2010
Avecia to expand QMS as oligonucleotides advance  Read More »
BioReliance

November 16, 2010
Aardema to serve as Tox-CSO  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: